Market Place
Sourcing Support
Fresenius Kabi`s Biologic Otulfi (Ustekinumab) Receives Approval in US
27 Sep 2024 //
FDA
Fresenius Kabi`s Generics Pantoprazole Sodium Receives Approval in US
01 Aug 2024 //
FDA
Fresenius Kabi USA`s Generics Daptomycin Receives Approval in US
01 Aug 2024 //
FDA
Fresenius Kabi Usa Generic Sodium Chloride Receives Approval in US
24 Jun 2024 //
FDA
Fresenius Kabi USA Wins Drug Shortage Guardian Award
06 Jun 2024 //
BUSINESSWIRE
Fresenius Kabi Usa`s Generic Adalimumab-Aacf Receives Approval in US
04 Jun 2024 //
FDA
Fresenius`s Biologic Stimufend (Pegfilgrastim) Receives Approval in the U.S.
01 Sep 2022 //
FDA
Fresenius Kabi Announces U.S. Availability of Cancer Therapeutic Thiotepa
29 Jul 2022 //
BUSINESSWIRE
Fresenius Kabi Expands Ready-to-Administer Portfolio with Glycopyrrolate Inj.
25 Jul 2022 //
BUSINESSWIRE
Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent
18 Jul 2022 //
BUSINESSWIRE
Fagron expands its US sterile compounding footprint with East coast acquisition
05 Jul 2022 //
GLOBENEWSWIRE
Fresenius Kabi USA`s Generic Kabilyte Receives Approval in the US
08 Jun 2022 //
FDA
Fresenius Kabi Introduces New Generic for Non-Squamous NSCLC
31 May 2022 //
BUSINESSWIRE
Dr. Brandee Pappalardo Joins Fresenius Kabi as CMO for N. America
18 May 2022 //
BUSINESSWIRE
Toxins In Silicone Tubing Leads To FDA Warning
09 May 2022 //
MEDTECH INSIGHT
Fresenius Kabi USA Generic Bortezomib Receives Approval in the U.S.
02 May 2022 //
FDA
Fresenius Kabi Introduces New Generic for the Treatment of Multiple Myeloma
02 May 2022 //
BUSINESSWIRE
Fresenius Kabi Introduces Calcium Gluconate in Sodium Chloride Injection
27 Apr 2022 //
BUSINESSWIRE
Fresenius Kabi USA,`s Generic Sodium Phosphate Receives Approval in the U.S.
30 Mar 2022 //
FDA
Fresenius Sues Zydus Over Patents for Rare Thyroid Disease Drug
30 Mar 2022 //
BLOOMBERGLAW
Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP
07 Mar 2022 //
BUSINESSWIRE
Fresenius & Phlow Corp. Form Alliance to Enhance Supply of Essential Medicines
14 Oct 2021 //
BUSINESSWIRE
FDA Issues Form 483 to Fresenius Kabi USA LLC
29 Jan 2021 //
FDA
Recall report: Fresenius Kabi yanks inflammatory med Ketorolac after finding
11 Jan 2021 //
ENDPTS
Fresenius Kabi USA`s Generic Potassium Cl: Sodium Cl Receives Approval In US
21 Sep 2020 //
FDA
Fresenius Kabi`s Generic Potassium Chloride Receives Approval In US
09 Sep 2020 //
FDA
Fresenius Kabi`s Generic Potassium Chloride Receives Approval In US
09 Sep 2020 //
FDA
Fresenius Kabi`s Generic Potassium Chloride Receives Approval In US
09 Sep 2020 //
FDA
Fresenius Kabi Introduces RFID Smart Labels for Essential Meds
21 Aug 2020 //
CONTRACTPHARMA
Fresenius Kabi`s Generic Oxacillin SodiumReceives Approval in US
25 Jul 2020 //
FDA
Fresenius Kabi Adds Micafungin for Inj to Expanding Anti-Infective Portfolio
12 May 2020 //
BUSINESSWIRE
Fresenius Kabi Introduces Heparin Sodium Injection
08 Nov 2019 //
BUSINESSWIRE
Enforcement Report - Week of July 24, 2019
24 Jul 2019 //
FDA
FRESENIUS KABI USA`s generic HALOPERIDOL LACTATE Receives Approval in US
01 Jul 2019 //
FDA
Fresenius Kabi`s Generic Micafungin Sodium Receives Approval in US
22 May 2019 //
FDA
Fresenius Kabi`s Generic Fentanyl Citrate Receives Approval in US
08 May 2019 //
FDA
Fresenius Kabi`s Generic Sodium Chloride Receives Approval in US
15 Mar 2019 //
FDA
Enforcement Report - Week of December 12, 2018
12 Dec 2018 //
FDA
Enforcement Report - Week of December 5, 2018
05 Dec 2018 //
FDA
Special 510(k)s: CDRH’s Proposed Program Expansion Draws Mixed Reactions
04 Dec 2018 //
RAPS
AbbVie settles Humira biosimilar dispute with Fresenius Kabi
19 Oct 2018 //
REUTERS
Fresenius Kabi USA`s Generic Arsenic Trioxide Receives Approval in US
05 Sep 2018 //
FDA
Fresenius Kabi USA`s Generic Posaconazole Receives Tentative Approval in US
17 Aug 2018 //
FDA
Naropin (ropivacaine hydrochloride) : Fresenius Kabi USA v. Custopharm, Inc.
07 Aug 2018 //
PATENT LITIGATION
Fresenius Kabi USA`s Generic Leucovorin Calcium Receives Approval In US
28 Jul 2018 //
FDA
